eMedicine Specialties > Dermatology > Mycobacterial Infections

Mycobacterium Avium-Intracellulare Infection

Author: Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Coauthor(s): Supriya Tomar, MD, Consulting Staff, Mohs College; Douglas W Kress, MD, Program Director, Medical Director of Clinical Services, Department of Dermatology, University of Pittsburgh Medical Center; Nicole Restauri, MD, Staff Physician, Radiology, University of Pittsburgh School of Medicine; Jessica M Allan, MD, Consulting Staff, Private Practice
Contributor Information and Disclosures

Updated: Jan 15, 2010

Introduction

Background

Mycobacterium avium-intracellulare (MAI, or MAC) is the atypical Mycobacterium most commonly associated with human disease. It is primarily a pulmonary pathogen that affects individuals with immune compromise secondary to AIDS, hairy cell leukemia, and immunosuppressive chemotherapy. In this clinical setting, MAI has been associated with osteomyelitis; tenosynovitis; synovitis; and disseminated disease involving the lymph nodes, the CNS, the liver, the spleen, and the bone marrow. Although the prevalence of MAI infection has increased following the AIDS epidemic, it remains a rare cause of skin disease. However, MAI has been found to cause cutaneous disease in individuals with immunocompetence and immunosuppression.
 
Also see the related eMedicine Infectious Diseases article Mycobacterium Avium-Intracellulare.

Pathophysiology

Mycobacterium avium-intracellulare (MAI, or MAC) is an acid-fast atypical Mycobacterium. The organism is ubiquitous in the environment, and it is the most common bacteria isolated from patients with AIDS. MAI causes cutaneous disease by 3 separate mechanisms, which occur in unique patient populations with different morphologic manifestations. MAI infection may involve the skin primarily via posttraumatic inoculation, secondarily as a manifestation of disseminated Mycobacterium avium-intracellulare (DMAI) systemic disease, and by direct extension as a complication of cervical lymphadenitis.

Primary cutaneous MAI infection generally occurs in hosts who are immunocompetent after traumatic introduction into the soft tissue. Local disease ensues, manifested primarily as nodules that may progress to ulcers. One case report described primary MAI infection resulting in a clinical picture resembling lupus vulgaris.1 Disseminated disease most commonly occurs in individuals who are immunosuppressed, and hematogenous seeding of the skin may result in a wide variety of skin lesions, including nodules and abscesses, panniculitis,2 folliculitis, and acute disease with hemorrhagic pustules.

MAI is the most common cause of pediatric cervical adenitis. Skin involvement in this setting is not uncommon and includes sinus track and abscess formation. Cervical adenitis rarely involves deeper structures, but it may result in extensive superficial destruction with cosmetic deformity.

Frequency

United States

In the United States, Mycobacterium avium-intracellulare (MAI, or MAC) infection is considered a nonreportable infectious disease. The US Centers for Disease Control and Prevention surveillance data from Houston and Atlanta suggest an incidence of 1 case per 100,000 persons per year. In 1994, the highest incidence of DMAI, 37,000 cases, was measured. Because DMAI infection often occurs in association with HIV, this was not surprising. Thus, the 1994 peak was coincident with the peak in the AIDS epidemic. One case series revealed cutaneous involvement in 6 of 30 cases of DMAI infection.

US Centers for Disease Control and Prevention data suggest that the incidence of MAI infection may be decreasing as a result of highly active antiretroviral therapy and antimicrobial prophylaxis. Primary cutaneous MAI infection is rare, with 12 cases reported in the literature prior to 1997. The degree to which skin involvement occurs as a sequela of cervical adenitis has not been well studied; however, the literature suggests that the risk of skin involvement increases with advanced disease.

Mortality/Morbidity

  • Primary cutaneous involvement does not usually result in systemic disease and most often occurs in otherwise healthy individuals; therefore, the prognosis is favorable because treatment is generally curative.
  • Disseminated disease resulting in cutaneous MAI infection occurs in individuals with underlying illnesses and may significantly increase morbidity in this population. Controversy remains regarding the impact of DMAI infection on life expectancy in patients with AIDS. However, untreated DMAI infection in this population is clearly associated with an increased mortality rate.
  • Cervical adenitis may cause local destruction of superficial structures and may result in cosmetic and functional impairment without treatment, but dissemination beyond the primary site is rare.

Race

No racial predilection has been noted for MAI infection.

Sex

No sexual predilection has been noted for MAI infection.

Age

Cutaneous MAI infection has been reported in all age groups.

  • Cervical adenitis most commonly affects children. One chart review series of 47 children with cervical adenitis revealed a median age of 3 years when the MAI infection was diagnosed by doctors.
  • Most case reports of primary cutaneous MAI infection have been in individuals aged 2-10 years, although adult cases have been described.
  • A literature review of 8 cases of cutaneous MAI infection occurring secondary to disseminated disease found a median patient age of 22.2 years, with a range of 2-28 years.

Clinical

History

Any history of the introduction of a foreign object (eg, needle, splinter) should be sought if Mycobacterium avium-intracellulare (MAI, or MAC) infection is suspected.

  • Cutaneous MAI infection should be suspected when an individual who is immunocompromised presents with obscure skin lesions. Additional symptoms, including fatigue, fever, diarrhea, weight loss, back or bone pain, shortness of breath, and/or cough may suggest disseminated disease.
  • Patients with MAI cervical adenitis may present with an indolent course of a unilaterally expanding mass in the neck.
  • Fever and other constitutional symptoms are generally absent.
  • Primary cutaneous MAI infection is most often the result of traumatic inoculation, although a specific history of trauma is generally absent.
  • Patients may describe the development of a single nodule or multiple nodules progressing over time into ulcerative lesions with or without serosanguineous exudates. Nodules may be tender.
  • Cutaneous MAI infection in an HIV-positive patient mimicking histoid leprosy has been reported.3
  • Henoch-Schönlein purpura associated with pulmonary MAI complex infection has been noted.4
  • MAI can be associated with osteomyelitis. Primary nontraumatic MAI complex osteomyelitis of the distal phalanx has occurred.5 Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor has been noted.
  • Subcutaneous and muscular abscesses due to MAI can occur as a manifestation of immune restoration in patients with AIDS.6
  • Murdoch and McDonald7 reported MAI cellulitis occurring with septic arthritis after joint injection.
  • Teraki et al has noted that MAI can be associated with Sweet syndrome.8
  • Faruqi et al noted that a positive antineutrophil cytoplasmic antibody (ANCA) test result can coexist with MAI, complicating diagnosis.9

Physical

  • Examination in the case of disseminated Mycobacterium avium-intracellulare (MAI, or MAC) infection may reveal a patient who is febrile with positive findings on lung examination and with findings of hepatosplenomegaly; lymphadenopathy; swollen, tender joints or focal neurologic deficits in the setting of painful, erythematous, indurated subcutaneous plaques; painful nodules and ulcers; folliculitis; or hemorrhagic pustules.
  • Patients with cervical adenitis due to MAI usually present with enlarged submandibular or submaxillary nodes.
  • Skin abscess and sinus tracks may be present. Sporotrichoid spread of cutaneous MAI complex infection can occur.10
  • Primary cutaneous MAI infection generally results in painful subcutaneous nodules and ulcers that occur on the extremities and the trunk. Lesions may be present in multiple stages of development, and nodules have been described as both flesh colored and purple-red.

Causes

Mycobacterium avium-intracellulare (MAI, or MAC) is the most common organism isolated from patients with AIDS.

  • Immunosuppression is a risk factor for disseminated disease.
  • Patients who are immunosuppressed and at risk for DMAI disease include those on immunosuppressive agents after undergoing transplantation and patients with leukemia and lymphoma.
  • No risk factors for primary cutaneous MAI infection or cervical adenitis are known.

More on Mycobacterium Avium-Intracellulare Infection

Overview: Mycobacterium Avium-Intracellulare Infection
Differential Diagnoses & Workup: Mycobacterium Avium-Intracellulare Infection
Treatment & Medication: Mycobacterium Avium-Intracellulare Infection
Follow-up: Mycobacterium Avium-Intracellulare Infection
References
[ CLOSE WINDOW ]

References

  1. Kullavanijaya P, Sirimachan S, Surarak S. Primary cutaneous infection with Mycobacterium avium intracellulare complex resembling lupus vulgaris. Br J Dermatol. Feb 1997;136(2):264-6. [Medline].

  2. Sanderson TL, Moskowitz L, Hensley GT, Cleary TJ, Penneys N. Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis. Arch Pathol Lab Med. Mar 1982;106(3):112-4. [Medline].

  3. Boyd AS, Robbins J. Cutaneous Mycobacterium avium intracellulare infection in an HIV+ patient mimicking histoid leprosy. Am J Dermatopathol. Feb 2005;27(1):39-41. [Medline].

  4. Yano S. Henoch-Schonlein purpura associated with pulmonary Mycobacterium avium-intracellulare complex. Intern Med. Sep 2004;43(9):843-5. [Medline].

  5. Whitaker MC, Lucas GL. Primary nontraumatic Mycobacterium avium complex osteomyelitis of the distal phalanx. Am J Orthop (Belle Mead NJ). May 2004;33(5):248-9. [Medline].

  6. Bachmeyer C, Thibaut M, Khuoy L, Danne O, Blum L. Subcutaneous and muscular abscesses due to Mycobacterium avium intracellulare in a patient with AIDS as a manifestation of immune restoration. Br J Dermatol. Feb 2004;150(2):397-8. [Medline].

  7. Murdoch DM, McDonald JR. Mycobacterium avium-intracellulare cellulitis occurring with septic arthritis after joint injection: a case report. BMC Infect Dis. Feb 26 2007;7:9. [Medline].

  8. Teraki Y, Ono S, Izaki S. Sweet's syndrome associated with Mycobacterium avium infection. Clin Exp Dermatol. Aug 2008;33(5):599-601. [Medline].

  9. Faruqi S, Kastelik JA, McGivern DV. Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA. Eur J Intern Med. May 2008;19(3):216-8. [Medline].

  10. Kayal JD, McCall CO. Sporotrichoid cutaneous Mycobacterium avium complex infection. J Am Acad Dermatol. Nov 2002;47(5 Suppl):S249-50. [Medline].

  11. Perrin C. A patient with acquired immunodeficiency syndrome (AIDS) and a cutaneous Mycobacterium avium intracellulare infection mimicking histoid leprosy. Am J Dermatopathol. Aug 2007;29(4):422. [Medline].

  12. Liou JH, Huang PY, Hung CC, Hsiao CH. Mycobacterial spindle cell pseudotumor of skin. J Formos Med Assoc. May 2003;102(5):342-5. [Medline].

  13. Shiomi T, Yamamoto T, Manabe T. Mycobacterial spindle cell pseudotumor of the skin. J Cutan Pathol. Apr 2007;34(4):346-51. [Medline].

  14. Starke JR. Management of nontuberculous mycobacterial cervical adenitis. Pediatr Infect Dis J. Jul 2000;19(7):674-5. [Medline].

  15. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med. Sep 16 1993;329(12):898-904. [Medline].

  16. Kerlikowske KM, Katz MH, Chan AK, Perez-Stable EJ. Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Arch Intern Med. Apr 1992;152(4):813-7. [Medline].

  17. [Guideline] Mofenson LM, Brady MT, Danner SP, et al. Mycobacterial infections. In: Guidelines for prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. MMWR Recomm Rep. Sep 4 2009;58(RR-11):19-28.

  18. [Guideline] Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. Sep 4 2009;58:1-166. [Medline].

  19. Vuppalapati G, Turner A, La Rusca I, Schonauer F. Mycobacterium avium infection involving skin and soft tissue of the hand treated by radical debridement and reconstruction in addition to multidrug chemotherapy. J Hand Surg Br. Dec 2006;31(6):693-4. [Medline].

  20. Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect. Dec 2007;55(6):484-7. [Medline].

  21. Bartralot R, Pujol RM, Garcia-Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol. Mar 2000;27(3):124-9. [Medline].

  22. Escalonilla P, Esteban J, Soriano ML, et al. Cutaneous manifestations of infection by nontuberculous mycobacteria. Clin Exp Dermatol. Sep 1998;23(5):214-21. [Medline].

  23. Friedman BF, Edwards D, Kirkpatrick CH. Mycobacterium avium-intracellulare: cutaneous presentations of disseminated disease. Am J Med. Aug 1988;85(2):257-63. [Medline].

  24. Hautmann G, Lotti T. Atypical mycobacterial infections of the skin. Dermatol Clin. Oct 1994;12(4):657-68. [Medline].

  25. Holland SM. Nontuberculous mycobacteria. Am J Med Sci. Jan 2001;321(1):49-55. [Medline].

  26. Horsburgh CR Jr, Gettings J, Alexander LN, Lennox JL. Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000. Clin Infect Dis. Dec 1 2001;33(11):1938-43. [Medline].

  27. Ichiki Y, Hirose M, Akiyama T, Esaki C, Kitajima Y. Skin infection caused by Mycobacterium avium. Br J Dermatol. Feb 1997;136(2):260-3. [Medline].

  28. Inwald D, Nelson M, Cramp M, Francis N, Gazzard B. Cutaneous manifestations of mycobacterial infection in patients with AIDS. Br J Dermatol. Jan 1994;130(1):111-4. [Medline].

  29. Maltezou HC, Spyridis P, Kafetzis DA. Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J. Nov 1999;18(11):968-70. [Medline].

  30. Marinho RO, Hutchison IL. Facial infection caused by Mycobacterium avium-intracellulare. J Oral Maxillofac Surg. Jun 2000;58(6):668-70. [Medline].

  31. Palenque E. Skin disease and nontuberculous atypical mycobacteria. Int J Dermatol. Sep 2000;39(9):659-66. [Medline].

  32. Tartaglione T. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Ther. Jul-Aug 1997;19(4):626-38; discussion 603. [Medline].

  33. Weitzul S, Eichhorn PJ, Pandya AG. Nontuberculous mycobacterial infections of the skin. Dermatol Clin. Apr 2000;18(2):359-77, xi-xii. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

infection, complex, MAI infection, MAC infection, DMAI disease, MAI, MAC, disseminated DMAI, cutaneous MAI, cervical adenitis, cervical lymphadenitis, atypical mycobacterial disease

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Optigenex Consulting fee Independent contractor

Coauthor(s)

Supriya Tomar, MD, Consulting Staff, Mohs College
Disclosure: Nothing to disclose.

Douglas W Kress, MD, Program Director, Medical Director of Clinical Services, Department of Dermatology, University of Pittsburgh Medical Center
Douglas W Kress, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Nicole Restauri, MD, Staff Physician, Radiology, University of Pittsburgh School of Medicine
Disclosure: Nothing to disclose.

Jessica M Allan, MD, Consulting Staff, Private Practice
Disclosure: Nothing to disclose.

Medical Editor

Takeji Nishikawa, MD, Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting; Medicis Honoraria Consulting; Celgene Honoraria Consulting

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds Investigator; Genentech Grant/research funds investigator; Centocor Consulting fee Consulting; Abbott Grant/research funds investigator; Abbott Consulting fee Consulting; Novartis  investigator; Pfizer Grant/research funds investigator; Celgene Consulting fee DMC Chair; NIAMS and NHLBI Grant/research funds investigator

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.